Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Arturo Casadevall, Liise‐anne Pirofski, Michael J. Joyner
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Early Outpatient Treatment for Covid-19 with Convalescent Plasma
David J. Sullivan, Kelly A. Gebo, Shmuel Shoham, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1700-1711
Open Access | Times Cited: 234
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 125
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
İlker Polatoğlu, Tülay Öncü Öner, Irem Dalman, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
Stephen A. Klassen, Jonathon W. Senefeld, Katherine A. Senese, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 64
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
Arturo Casadevall, Quigly Dragotakes, Patrick W. Johnson, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 59
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies
Rohit Singh, Pankaj Chandley, Soma Rohatgi
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 886-897
Open Access | Times Cited: 28
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia
Katharine J. Bar, Pamela A. Shaw, Grace Choi, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 24
Open Access | Times Cited: 40
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
David J. Sullivan, Kelly A. Gebo, Shmuel Shoham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 36
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
Juan G. Ripoll, Ellen K. Gorman, Justin E. Juskewitch, et al.
Blood Advances (2022) Vol. 6, Iss. 23, pp. 5951-5955
Open Access | Times Cited: 24
Antibody-Based Immunotherapies as a Tool for Tackling Multidrug-Resistant Bacterial Infections
António M. M. Seixas, Sílvia A. Sousa, Jorge H. Leitão
Vaccines (2022) Vol. 10, Iss. 11, pp. 1789-1789
Open Access | Times Cited: 24
Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
Scott A. McConnell, Jaiprasath Sachithanandham, Nathan J. Mudrak, et al.
Cell chemical biology (2023) Vol. 30, Iss. 7, pp. 726-738.e4
Open Access | Times Cited: 12
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Juanjie Tang, Youri Lee, Supriya Ravichandran, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103006-103006
Open Access | Times Cited: 30
Rhodococcus equifoal pneumonia: Update on epidemiology, immunity, treatment and prevention
Angela I. Bordin, Laura Huber, Macarena G. Sanz, et al.
Equine Veterinary Journal (2022) Vol. 54, Iss. 3, pp. 481-494
Closed Access | Times Cited: 20
The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox
Evan M. Bloch, David J. Sullivan, Shmuel Shoham, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 19
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
Han-Sol Park, Anna Yin, Caelan Barranta, et al.
JCI Insight (2024) Vol. 9, Iss. 8
Open Access | Times Cited: 3
Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation
Hyung Park, Chang Yu, Liise‐anne Pirofski, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Hyperimmune Globulins for the Management of Infectious Diseases
Ilaria Pati, Mario Cruciani, Fabio Candura, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1543-1543
Open Access | Times Cited: 8
The coevolution of Covid-19 and host immunity
Azizul Haque, Anudeep B. Pant
Exploration of Medicine (2024), pp. 167-184
Open Access | Times Cited: 2
Generating the Evidence Base for Convalescent Plasma Use for a New Infectious Disease
Hyunah Yoon, Liise‐anne Pirofski
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV‐2 neutralizing antibodies in hospitalized patients with COVID‐19
Cristina Sanz, Meritxell Nomdedéu, Arturo Pereira, et al.
Transfusion (2022) Vol. 62, Iss. 5, pp. 974-981
Open Access | Times Cited: 13
The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation
Chenxu Guo, Shang Jui Tsai, Yiwei Ai, et al.
Science Advances (2022) Vol. 8, Iss. 51
Open Access | Times Cited: 13
Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants?
Daniele Focosi, Massimo Franchini, Michael J. Joyner, et al.
Vox Sanguinis (2022) Vol. 117, Iss. 5, pp. 641-646
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top